AKT1 and triple-A syndrome: Based on our results, melatonin attenuated nicotine-related AAA development by restoring the VSMC phenotype, inhibiting the AKT-mTOR pathway, ameliorating autophagy dysfunction, and promoting anti-inflammatory and antioxidant activities.